REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Trial NCT06399705
Access comprehensive clinical trial information for NCT06399705 through Pure Global AI's free database. This Phase 3 trial is sponsored by Weill Medical College of Cornell University and is currently Not yet recruiting. The study focuses on Coronary Artery Disease. Target enrollment is 600 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Weill Medical College of Cornell University
Timeline & Enrollment
Phase 3
May 01, 2024
Jan 01, 2039
Primary Outcome
Hierarchical composite of all-cause death and time-averaged change from baseline in generic quality of life using the SF-12v2
Summary
This is a research study in minorities to compare the outcomes of two procedures that restore
 blood flow to the arteries of the heart. In one procedure the blockages are ballooned and
 then stented with a small wire mesh tube through a small incision in the wrist or the groin.
 The other procedure is an open-heart operation in which healthy blood vessels from inside the
 chest, leg, and/or forearm are used to bypass the blockages (like a detour). Outcomes will
 be measured by comparing survival and improvement in quality-of-life.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06399705
Non-Device Trial